FME:ETR
Fresenius Medical Care AG
39,71 €
arrow_downward
-0,35%(-0,14) 1D
17 նոյ, 17:36:16 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for FME...
Open
39,79 €
High
39,97 €
Low
39,57 €
Mkt. cap
10,66 մլրդ
Avg. vol.
1,11 մլն
Volume
628,06 հզր
Dividend
3,75%
Quarterly dividend
0,37 €
Ex-dividend date
22 մյս, 2026 թ.
P/E ratio
13,27
52-wk high
45,90 €
52-wk low
34,57 €
EPS
2,99 €
Shares outstanding
268,56 մլն
No. of employees
106 հզր
Open
39,79 €
High
39,97 €
Low
39,57 €
Mkt. cap
10,66 մլրդ
Avg. vol.
1,11 մլն
Volume
628,06 հզր
Dividend
3,75%
Quarterly dividend
0,37 €
Ex-dividend date
22 մյս, 2026 թ.
P/E ratio
13,27
52-wk high
45,90 €
52-wk low
34,57 €
EPS
2,99 €
Shares outstanding
268,56 մլն
No. of employees
106 հզր
News stories
From web sources and news partners
TradingView
·
1 օր առաջ
Weekly Recap: Fresenius share sale and Barclays downgrades FME
Profile
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease, which requires patients to undergo dialysis 3 times per week for the rest of their lives.
With a global headquarters in Bad Homburg vor der Höhe, Germany, and a North American headquarters in Waltham, Massachusetts, it has a 38% market share of the dialysis market in the United States. It also operates 42 production sites, the largest of which are in the U.S., Germany, and Japan.
The company is 32% owned by Fresenius and, as of 2020, generates around 50% of the group's revenue.
As of 2024, the company was ranked as #612 on the World's Best Employers list published by Forbes. Wikipedia
About Fresenius Medical Care AG
CEOHelen Giza
Employees106 հզր
Founded1996
Headquarters-
SectorHealth Care
IndustryHealth care provider
Websitefreseniusmedicalcare.com